Amifostine stimulates the formation of hematopoietic bone marrow progenitors from B-cell chronic lymphocytic leukemia. 2004

Costas Tsatalas, and Emmanuel Spanoudakis, and Despoina Pantelidou, and Dimitris Margaritis, and Ioannis Kotsianidis, and Panagiota Chalkia, and Gregory Tripsianis, and Ioanna Basdiara, and Zafiris Kartasis, and Apostolos Karakolios, and George Bourikas
Hematology Department, Democritus University of Thrace School of Medicine, Alexandroupolis, Greece. ktsatala@med.duth.gr

Amifostine is a phosphorylated aminothiol that not only protects hematopoietic progenitor cells from chemotherapy and radiotherapy, but also stimulates normal hematopoiesis. The effect of amifostine on the in vitro growth of hematopoietic progenitors derived from B-cell chronic lymphocytic leukemia(B-CLL) was investigated. The colony-forming units (CFU)-granulocyte macrophage (CFU-GM), the burst-forming units-erythroid (BFU-E) and the CFU-granulocyte erythroid macrophage megakaryocytes (CFU-GEMM) increased 38, 20 and 100%, respectively, after the incubation with amifostine. There was no statistical difference in the in vitro progenitor growth of patients grouped according to their disease stage, bone marrow lymphocytic infiltration or therapy. Our data indicate that apart from cytoprotection the parallel use of amifostine and chemotherapy in patients with B-CLL could enhance bone marrow recovery.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011837 Radiation-Protective Agents Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. Radiation Protectant,Radiation Protective Agent,Radiation-Protective Agent,Radiation-Protective Drug,Radioprotective Agent,Radioprotective Agents,Radioprotective Drug,Agents, Radiation-Protective,Radiation Protectants,Radiation Protective Agents,Radiation-Protective Drugs,Radiation-Protective Effect,Radiation-Protective Effects,Radioprotective Drugs,Agent, Radiation Protective,Agent, Radiation-Protective,Agent, Radioprotective,Agents, Radiation Protective,Agents, Radioprotective,Drug, Radiation-Protective,Drug, Radioprotective,Drugs, Radiation-Protective,Drugs, Radioprotective,Effect, Radiation-Protective,Effects, Radiation-Protective,Protectant, Radiation,Protectants, Radiation,Protective Agent, Radiation,Protective Agents, Radiation,Radiation Protective Drug,Radiation Protective Drugs,Radiation Protective Effect,Radiation Protective Effects
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004999 Amifostine A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia. Ethiofos,Gammaphos,APAETP,Amifostine Anhydrous,Amifostine Disodium Salt,Amifostine Monohydrate,Amifostine Monohydrochloride,Amifostine Trihydrate,Aminopropyl Aminoethylthiophosphate,Aminopropylaminoethylthiophosphate,Aminopropylaminoethylthiophosphoric Acid,Ethanethiol, 2-((3-aminopropyl)amino)-, dihydrogen phosphate (ester), trihydrate,Ethiofos Anhydrous,Ethyol,NSC-296961,S-(N-(3-Aminopropyl)-2-aminoethyl)thiophosphoric Acid,WR-2721,YM-08310,NSC 296961,NSC296961,WR 2721,WR2721,YM 08310,YM08310
D005260 Female Females
D006410 Hematopoiesis The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY). Hematopoiesis, Medullary,Haematopoiesis,Medullary Hematopoiesis
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Costas Tsatalas, and Emmanuel Spanoudakis, and Despoina Pantelidou, and Dimitris Margaritis, and Ioannis Kotsianidis, and Panagiota Chalkia, and Gregory Tripsianis, and Ioanna Basdiara, and Zafiris Kartasis, and Apostolos Karakolios, and George Bourikas
October 1998, Leukemia,
Costas Tsatalas, and Emmanuel Spanoudakis, and Despoina Pantelidou, and Dimitris Margaritis, and Ioannis Kotsianidis, and Panagiota Chalkia, and Gregory Tripsianis, and Ioanna Basdiara, and Zafiris Kartasis, and Apostolos Karakolios, and George Bourikas
December 2003, Haematologica,
Costas Tsatalas, and Emmanuel Spanoudakis, and Despoina Pantelidou, and Dimitris Margaritis, and Ioannis Kotsianidis, and Panagiota Chalkia, and Gregory Tripsianis, and Ioanna Basdiara, and Zafiris Kartasis, and Apostolos Karakolios, and George Bourikas
August 2000, Leukemia,
Costas Tsatalas, and Emmanuel Spanoudakis, and Despoina Pantelidou, and Dimitris Margaritis, and Ioannis Kotsianidis, and Panagiota Chalkia, and Gregory Tripsianis, and Ioanna Basdiara, and Zafiris Kartasis, and Apostolos Karakolios, and George Bourikas
January 2021, iScience,
Costas Tsatalas, and Emmanuel Spanoudakis, and Despoina Pantelidou, and Dimitris Margaritis, and Ioannis Kotsianidis, and Panagiota Chalkia, and Gregory Tripsianis, and Ioanna Basdiara, and Zafiris Kartasis, and Apostolos Karakolios, and George Bourikas
October 2004, Analytical and quantitative cytology and histology,
Costas Tsatalas, and Emmanuel Spanoudakis, and Despoina Pantelidou, and Dimitris Margaritis, and Ioannis Kotsianidis, and Panagiota Chalkia, and Gregory Tripsianis, and Ioanna Basdiara, and Zafiris Kartasis, and Apostolos Karakolios, and George Bourikas
June 1995, Leukemia,
Costas Tsatalas, and Emmanuel Spanoudakis, and Despoina Pantelidou, and Dimitris Margaritis, and Ioannis Kotsianidis, and Panagiota Chalkia, and Gregory Tripsianis, and Ioanna Basdiara, and Zafiris Kartasis, and Apostolos Karakolios, and George Bourikas
March 2019, Leukemia,
Costas Tsatalas, and Emmanuel Spanoudakis, and Despoina Pantelidou, and Dimitris Margaritis, and Ioannis Kotsianidis, and Panagiota Chalkia, and Gregory Tripsianis, and Ioanna Basdiara, and Zafiris Kartasis, and Apostolos Karakolios, and George Bourikas
July 2000, American journal of clinical pathology,
Costas Tsatalas, and Emmanuel Spanoudakis, and Despoina Pantelidou, and Dimitris Margaritis, and Ioannis Kotsianidis, and Panagiota Chalkia, and Gregory Tripsianis, and Ioanna Basdiara, and Zafiris Kartasis, and Apostolos Karakolios, and George Bourikas
June 2002, Southern medical journal,
Costas Tsatalas, and Emmanuel Spanoudakis, and Despoina Pantelidou, and Dimitris Margaritis, and Ioannis Kotsianidis, and Panagiota Chalkia, and Gregory Tripsianis, and Ioanna Basdiara, and Zafiris Kartasis, and Apostolos Karakolios, and George Bourikas
March 2003, Southern medical journal,
Copied contents to your clipboard!